All In Biotech

Drug Trial Radar · NCT07491458

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

A Parallel Treatment Group, Phase 2a, Double-blind, 4-arm Trial to Evaluate the Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Male and Female Participants Aged 30 Years or Older With Metabolic Dysfunction-associated Steatohepatitis (MASH)

Last checked: Nov 19, 2026Latest source record: May 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Feb 13, 2026

Primary completion

Feb 2027

Study completion Feb 2028

Sponsor

Lead sponsor
Rivus Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Mar 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Rivus Pharmaceuticals. Inc. is sponsoring this research study to assess the safety and tolerability of HU6 as a possible treatment for patients diagnosed with metabolic dysfunction-associated steatohepatitis (MASH). The study will also assess safety, pharmacokinetics (PK) and changes in liver fat content related to patients diagnosed with MASH.

Conditions

  • MASH - Metabolic Dysfunction-Associated Steatohepatitis

Interventions

  • HU6Drug

    HU6 is being evaluated for efficacy in MASH

  • PlaceboOther

    Placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number and Percentage of Adverse Events (AEs)Time frame: 26 weeks
  2. Percent change from baseline to Week 26 In Liver Fat Assessed by MRI-PDFFTime frame: 26 weeks
  3. Percentage of participants with Liver Fat reduction by ≥30% Assessed by MRI-PDFFTime frame: 26 weeks
  4. Area Under the Plasma Concentration-Time Curve (AUC)Time frame: 26 weeks
  5. Trough Plasma Concentration (Ctrough)Time frame: 26 weeks
  6. Maximum Observed Plasma Concentration (Cmax)Time frame: 26 weeks
  7. Time to Maximum Plasma Concentration (Tmax)Time frame: 26 weeks
  8. Plasma Clearance of drug after extravascular administration (CL/F)Time frame: 26 weeks
  9. Volume of distribution after extravascular administration (V/F)Time frame: 26 weeks
  10. Drug elimination half-life (t½)Time frame: 26 weeks

Locations

31 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Liver Health - Chandler

    Chandler, Arizona · Recruiting

  • Arizona Liver Health - Peoria

    Peoria, Arizona · Recruiting

  • Arizona Liver Health - Tucson

    Tucson, Arizona · Recruiting

  • Baptist Health Center for Clinical Research

    Little Rock, Arkansas · Recruiting

  • National Institute of Clinical Research

    Garden Grove, California · Recruiting

  • Catalina Research Institute

    Montclair, California · Recruiting

  • Knowledge Research Center

    Orange, California · Recruiting

  • Charter Research LLC - Orlando

    Orlando, Florida · Recruiting

  • Charter Research LLC - Chicago

    Chicago, Illinois · Recruiting

  • Delta Research Partners of Bastrop, LLC

    Bastrop, Louisiana · Recruiting

  • Delta Research Partners of West Monroe, LLC

    West Monroe, Louisiana · Recruiting

  • Clinical Research Institute of Michigan

    Clinton Township, Michigan · Recruiting

  • Nucleus Network Minneapolis

    Saint Paul, Minnesota · Recruiting

  • Kansas City Research Institute

    Kansas City, Missouri · Recruiting

  • KAD Clinical Research

    St Louis, Missouri · Recruiting

  • Jubilee Clinical Research, LLC.

    Las Vegas, Nevada · Recruiting

  • Coastal Research Institute

    Fayetteville, North Carolina · Recruiting

  • Clinical Research Institute of Ohio, LLC (CRIOH)

    Westlake, Ohio · Recruiting

  • Tekton Research - Yukon

    Yukon, Oklahoma · Recruiting

  • Innovative Clinical Research, LLC

    Clarksville, Tennessee · Recruiting

  • IMA Clinical Research (Austin)

    Austin, Texas · Recruiting

  • Pinnacle Clinical Research - Austin

    Austin, Texas · Recruiting

  • Bellaire Clinical Research, LLC

    Bellaire, Texas · Recruiting

  • Pinnacle Clinical Research - Corpus Christi

    Corpus Christi, Texas · Recruiting

  • Pinnacle Clinical Research - Georgetown

    Georgetown, Texas · Recruiting

  • HRI - Medical Center, LLC

    Houston, Texas · Recruiting

  • Houston Research Institute

    Houston, Texas · Recruiting

  • HRI - Pasadena, LLC

    Pasadena, Texas · Recruiting

  • Quality Research

    San Antonio, Texas · Recruiting

  • Pinnacle Clinical Research - San Antonio

    San Antonio, Texas · Recruiting

  • HRI - Sugarland, LLC

    Sugar Land, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.